Non-Alcoholic Fatty Liver Disease: New Research Highlights Role of Exercise and Diet in Prevention

Strategic Insights -

Researchers at the University of North Carolina Greensboro have published a new study shedding light on the importance of exercise and diet in preventing non-alcoholic fatty liver disease (NAFLD). The study focuses on the role of cholesterol and triglycerides in the development of NAFLD and highlights the benefits of aerobic exercise and resistance training in reducing the risk of metabolic syndrome (MetSyn) and NAFLD. The research emphasizes the need for individuals to modify their diet, achieve optimal exercise levels, and maintain a healthy weight to prevent NAFLD.

Key Takeaways:

  • The study emphasizes the importance of cholesterol and triglycerides in the development of NAFLD, with elevated blood levels of these lipids remaining a major public health problem in the United States.
  • Aerobic exercise, especially at high intensities, is effective in reducing risk factors for MetSyn and NAFLD by optimizing muscle and liver function and health.
  • Resistance training is also beneficial in affecting some MetSyn factors and can help in reducing the risk of NAFLD.
  • Modifying diet, achieving optimal exercise levels, and maintaining proper weight are crucial in treating NAFLD.
  • The study highlights the implementation of both aerobic exercise and resistance training in the upper range of recommendations for improved muscle and liver function.

Statistics:

  • Elevated blood cholesterol and triglyceride levels remain major United States Public Health problems, with genetics, diet, exercise, and physical activity affecting blood and tissue lipids and lipoproteins.
  • Peripheral tissues, especially muscle and the liver, function in maintaining proper blood and tissue lipid and lipoprotein levels.
  • For MetSyn factors, optimal benefits and improved muscle and liver function are obtained when aerobic exercise is completed in the upper PA range of the recommendations.
  • In 1999, the World Health Organization published the first criteria for metabolic syndrome (MetSyn), but in 2001 the National Cholesterol Education Program's Adult Treatment Panel III published the widely used MetSyn criteria.

Sources:

  • Skeletal Muscle and Cardiovascular Health. Antiviral Drug Discovery and Development, 2025;1478:631-659.
  • A news report by NewsRx, Researchers from University of North Carolina Greensboro Report Details of New Studies and Findings in the Area of Non-Alcoholic Fatty Liver Disease (Skeletal Muscle and Cardiovascular Health). Cardiovascular Week. September 15, 2025; p 2647.